Unacceptable variation in screening colonoscopy

Abstract

Fixing it will require strategic investment in data collection and infrastructure

European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission

“…For colorectal cancer, employing the Faecal Immunochemical Test (FIT) as a decision tool for triaging patients for colonoscopy was successfully employed to ensure early detection of colorectal cancer, despite the impact of COVID-19 and national lockdowns on the urgent diagnostic pathway. [160][161][162] Not only did this approach help save lives, it also allowed colonoscopy capacity to be managed more efficiently. 162 In lung cancer, low-dose computed tomography (LDCT), can be targeted to at-risk populations.…”

Rates of colorectal cancer after negative colonoscopies vary by provider, study finds

“…Responding to the paper in a linked editorial,2 a group of researchers said, “This heterogeneity between providers is likely to affect outcomes, and will be of concern to patients, clinicians, and providers. The inconsistencies seem linked to training and accreditation processes and are therefore amenable to improvement.…”